By Market & Region

New York – October 01, 2026 -- Sharon AI Holdings Inc. (NASDAQ: SHAZ) has closed its inaugural US$356 million committed senior secured, GPU-backed SPV debt facility, priced at a fixed rate of 9.95% excluding fees.

Facility backs GPU deployment for customer contracts

The debt is secured against the Company's GPUs and associated cash flows, funding the deployment of compute infrastructure dedicated to signed customer contracts. The facility supports Sharon AI's plan to build out more than 68,000 NVIDIA GPUs by mid-2027 and is the first in an expected series of GPU financings.

Goldman Sachs and private credit funds join syndicate

The facility drew marquee Australian, Asian and global investors, including Goldman Sachs and select large private credit funds. Jarden Australia acted as sole financial advisor and arranger on the transaction.

Boston – October 01, 2026 -- HoneyNaps, an AI-based sleep health technology company, has completed registration as a clinical research organization (CRO) with South Korea's National Enterprise for Clinical Trials (KoNECT), broadening its role in pharmaceutical and medical device trials worldwide.

HoneyNaps secures CRO registration with KoNECT, expanding multicenter trial capacity

The company has supported clinical trials involving more than 10,000 participants and can now operate multicenter, multidisciplinary studies under its new CRO status. The registration formalizes HoneyNaps' position as a provider of standardized sleep data analysis for pharmaceutical companies, medical device developers, and research organizations.

Dublin – October 01, 2026 -- Neuromod Devices has appointed Joe Ghiz as Chief Commercial Officer and Shannon Basham as VP of Channel Development, moves aimed at accelerating global commercial expansion of its tinnitus treatment device, Lenire.

San Jose, Calif. – October 01, 2026 -- AppZen has launched ZenLM Plus, a family of finance-specialized large language models that outperformed seven frontier AI models on expense audit accuracy while cutting inference costs, the company announced.

Houston and Düsseldorf – October 01, 2026 -- Uniper has reserved future production capacity from Syzygy Plasmonics' NovaSAFTM biogas-to-sustainable aviation fuel platform, joining a growing list of fuel buyers backing the technology ahead of a final investment decision on the company's first commercial plant in Uruguay.

Uniper locks in dual-certified SAF supply to meet EU mandate volumes

The agreement secures capacity under Syzygy's dual-certified pathway, which qualifies for both bio-based and RFNBO (renewable fuels of non-biological origin) SAF categories under European Union mandates. The deal adds commercial weight to Syzygy's planned NovaSAF facilities across Central and South America, with NovaSAF-1 in Uruguay now approaching final investment decision.

Tel Aviv, Israel – October 01, 2026 -- Lutris Pharma reported that its topical B-Raf inhibitor LUT014 achieved Treatment Success in 71.8% of patients with EGFR inhibitor-induced acneiform rash, compared with 38.5% on placebo (p=0.003), in updated Phase 2 data presented at the 35th EADV Congress in Vienna.

LUT014 0.1% gel cuts clinician-assessed rash severity and patient symptom burden

Among the composite endpoint's components, 56.4% of patients on LUT014 0.1% achieved at least a one-grade improvement on the CTCAE v5.0 acneiform rash scale versus 15.4% on placebo (p=0.0002). Using the FACT-EGFRI-18 patient-reported symptom score, 53.8% of treated patients reported at least a five-point improvement versus 28.2% on placebo (p=0.021).

Denver – October 01, 2026 -- LandGate has expanded its spatial intelligence platform to track more than 2,100 data center facilities across 10 European markets, adding site-level power, permitting and connectivity data to its existing U.S. coverage.

The expansion follows LandGate's acquisition by Wood Mackenzie in June 2026 and positions the company as a supplier of site-selection intelligence for hyperscale and AI-driven data center developers operating across Europe.

UK leads European coverage with 500+ facilities amid 70 GW of pending connection requests

The United Kingdom dominates LandGate's European dataset with more than 500 tracked facilities concentrated in the London and Slough corridor, where power connection requests now exceed 70 GW. Germany follows with 450+ facilities centered in Frankfurt, where the EnEfG Act will require new builds to hit a PUE of 1.2 or lower from July 2026 and shift to 100% renewable electricity by 2027.

Paramus, N.J. – October 01, 2026 -- NS Pharma, Inc. reported 5-year efficacy and safety data showing its investigational therapy brogidirsen maintained or improved motor function in Duchenne muscular dystrophy (DMD) patients amenable to exon 44 skipping, with zero treatment discontinuations across the study period.

Six-participant trial records no serious adverse events over five years

The data, presented by Japan's National Center of Neurology and Psychiatry (NCNP) at the 31st annual International Congress of the World Muscle Society in Hiroshima, Japan, covered an open-label extension of an investigator-initiated clinical trial. All six participants received weekly intravenous dosing of brogidirsen (NS-089/NCNP-02), an antisense oligonucleotide co-discovered by Nippon Shinyaku and NCNP. After five years of administration, no serious or severe adverse events, anaphylaxis, or discontinuations tied to long-term dosing were recorded.

Dallas – October 01, 2026 -- Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accepted and granted priority review to Nanoscope Therapeutics' New Drug Application for MOGENRY (sonpiretigene isteparvovec, MCO-010), an optogenetic gene therapy for inherited retinal dystrophies (IRDs). If approved by the Ministry of Health, Labour and Welfare, MOGENRY would become the first disease-agnostic treatment available to IRD patients in Japan, a condition caused by mutations across more than 250 genes that leads to progressive photoreceptor loss and blindness.

Bethlehem – October 01, 2026 -- Kerry has opened its first manufacturing facility in Pennsylvania, a coffee extraction plant in Bethlehem that significantly expands the company's hot and cold brew capacity for North American customers.

Kerry cuts ribbon on Bethlehem plant with independent hot and cold brew lines

The facility, first announced in September 2025, officially opened September 30 with a ceremony attended by customers, industry partners and government officials. The site uses advanced extraction, concentration and thermal processing technologies to produce formulation-specific coffee ingredients for ready-to-drink beverages, alcoholic drinks, ice cream and savory sauces. Its independent extraction lines are designed to scale as customer demand increases.

Philadelphia – October 01, 2026 -- Children's Hospital of Philadelphia (CHOP) has officially installed Joseph Mitchell, MD, as President and Chief Executive Officer, succeeding Madeline Bell after her nearly four-decade tenure and 11 years as CEO.

Mitchell completes an 18-month transition after joining CHOP as President in April 2025

Mitchell spent the past year and a half working alongside CHOP leadership, clinicians, researchers and community partners ahead of taking full control of the nation's first children's hospital, an institution founded more than 170 years ago.

Pensacola, Fla. – October 01, 2026 -- Baptist Health Care and PAM Health have restructured their joint venture, adding 40 acute care beds at Baptist Hospital and building a freestanding 60-bed inpatient rehabilitation hospital at Baptist Medical Park – Nine Mile, pushing Baptist Hospital's total bed count from 279 to 319.

Revised plan scraps original 40-bed rehab unit for larger freestanding facility

The updated agreement replaces a plan first announced in early 2025, which called for a 40-bed inpatient rehabilitation hospital housed within the Henderson Health Center on the Baptist Hospital campus. Under the new structure, PAM Health and Baptist Health Care will instead construct a standalone 60-bed rehabilitation hospital at the Nine Mile campus, freeing the Henderson Health Center space for conversion into a 40-bed acute care unit.

Manama – October 01, 2026 -- The Bahrain Economic Development Board will convene the fourth edition of Gateway Gulf on November 1-2, 2026, at the Four Seasons Hotel Bahrain Bay, building on a 2025 edition that generated more than USD 17 billion in announced transactions and investment commitments.

Invitation-only forum targets 200 senior decision-makers across five continents

The event, themed 'Reimagining Global Partnerships, Powering Sustainable Growth,' will gather ministerial officials, chief executives and investors from the Middle East, Asia, Europe, Latin America and North America. Bahrain's public and private sector representatives will join 200 senior decision-makers for two days of curated networking, private meetings and investment showcases.

San Francisco -- October 1, 2026 -- Beyond, a short-term rental revenue management platform, has launched three major features, Owner Hub, Advanced Connectivity, and Performance Manager, bundled with more than 40 additional product updates in its October 2026 Horizons release.

Owner Hub cuts owner-reporting time from 20 minutes to 2 minutes per report

Owner Hub consolidates three existing tools, Owner Projections, Listing Lens, and Owner Reports, into a single workflow for property managers. Running a revenue projection for one listing now takes 1 minute instead of 60, reviewing a listing via Listing Lens drops from 30 minutes to 1 minute, and building an owner report falls from 20 minutes to 2 minutes. Owner Projections generates three scenario-based revenue forecasts from any address or listing URL without a PMS connection, while Owner Reports delivers owner-ready summaries with market context and an editable AI narrative.

Toronto – October 01, 2026 -- Mayfair Gold Corp. (TSXV: MFG) (NYSE American: MINE) has signed a subscription agreement for a C$10 million strategic equity investment from Macquarie Bank Limited and a non-binding term sheet for a proposed C$300 million project finance facility, bringing the total financing package for its Fenn-Gib Gold Project to up to C$310 million.

Macquarie buys in at a 10% premium to fund Fenn-Gib's Timmins development

Macquarie will acquire Mayfair common shares at C$4.26 each, a 10% premium to the 5-day volume-weighted average price through September 30, 2026, subject to TSX Venture Exchange approval. The proposed C$300 million facility, which includes up to C$20 million of capitalized interest, would cover the majority of the C$450 million initial development capital outlined in Mayfair's 2026 Pre-Feasibility Study for Fenn-Gib, located in the Timmins region of Northern Ontario.

Palo Alto, Calif. -- October 1, 2026 -- Armadin, an AI-native cybersecurity company, has raised $255.5 million in a Series B round that pushes its valuation above $2.5 billion just seven months after launching from stealth. The round was co-led by Andreessen Horowitz (a16z) and Accel, with new investors Bain Capital Ventures and Redpoint joining. Existing backers 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures also returned, lifting Armadin's total funding to $445 million.

New York – October 01, 2026 -- Affiliated Advisors has added True Prosperity Advisors, a Rockford, Illinois-based advisory firm managing approximately $162 million in client assets, which previously operated under Baird.

True Prosperity Advisors exits Baird for Affiliated Advisors' growth platform

The firm is led by Financial Advisor Gary Love, CFP, CPWA, CEPA, alongside Registered Assistant Simeon Hanson. The team cited a need for a partner combining personalized support with scalable growth resources as the reason for the transition.

Advisor cites access to broader technology and wealth management tools

Through Affiliated Advisors, the team gains business management and operational support intended to help run efficient, growth-oriented practices. The platform also provides investment solutions, technology, financial planning resources and wealth management capabilities.

Rimini, Italy – October 01, 2026 -- Ecomondo 2026 will gather roughly 1,800 exhibiting brands at Rimini Expo Centre from November 3 to 6, with international exhibitor participation rising 10% year-on-year, organizer Italian Exhibition Group (IEG) announced.

Show footprint expands to 169,000 square metres across 30 halls

The 29th edition of the circular and regenerative economy event will occupy 169,000 square metres and span 30 exhibition halls. More than 1,000 hosted buyers from around the world are expected, backed by support from the Italian Ministry of Foreign Affairs and International Cooperation (MAECI) and the Italian Trade Agency (ICE), according to Event Director Alessandra Astolfi.

Beijing and Tel Aviv – October 01, 2026 -- ADAMA Ltd. (SZSE: 000553) has launched Actavan®, a plant-based fungicide for grapes, in Australia and New Zealand, offering growers a zero-residue tool against Botrytis with no pre-harvest interval.

Beet-extract compound activates grapevine immune defenses before infection

Actavan® is a Systemic Acquired Resistance (SAR) elicitor derived from beet extract. It triggers genes that produce enzymes degrading pathogen cell walls while stimulating antimicrobial phytoalexins, activating the plant's own defense response ahead of fungal attack.

Birkirkara – October 01, 2026 -- Gentoo Media Inc. has called an Extraordinary General Meeting of Shareholders for 2 November 2026 in Stockholm to approve a capital structure overhaul that would pave the way for a directed share issue fully underwritten by three of its largest shareholders.

Board seeks to raise authorized Common Stock to 250 million shares and create a new Class Z class

The Board of Directors is proposing a Third Amended and Restated Certificate of Incorporation that would lift authorized Common Stock from 200,000,000 to 250,000,000 shares, $0.001 par value each, while creating an additional class of 100,000,000 shares designated Class Z Common Stock. As of the notice date, Gentoo Media had 134,707,976 shares of Common Stock outstanding, each carrying one vote.